Anti‐inflammatory effects of long‐acting β‐agonists in asthma
- 1 October 1995
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 25 (10) , 912-914
- https://doi.org/10.1111/j.1365-2222.1995.tb00391.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Blood eosinophil numbers and activity during 24 hours: Effects of treatment with budesonide and bambuterolJournal of Allergy and Clinical Immunology, 1992
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.BMJ, 1990
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDYThe Lancet, 1989
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988